The PRIMACYT Cell Culture Technology GmbH has developed serum-free long-term culture techniques for hepatocytes. These technologies allow utilization of human and other mammalian hepatocytes as biosensors for screening purposes, while the hepatocyte specific functions remain intact. On this basis, new innovative products and services will be created to provide pharmaceutical and biotech companies as well as public research institutions with state of the art solutions for their specific demands.
Mikroskopische Aufnahme einer humanen Leberzelle, Primacyt GmbH
The major advantages of this hepatocyte culture system are its robustness and the fact that the hepatocytes remain differentiated and functional for several weeks. Preliminary studies have revealed that repetitive cycles of drug administrations can be applied to the cells. In other words, the hepatocytes may not only be used for one experiment, but instead can be "recycled" and may be used for a second, a third or even a fourth round of experiments. Thereby, the system is designed to reduce the number of animal experiments and to reduce the costs of preclinical studies.
The company is presenting its human hepatocyte culture system HEPAC2 at the annual Experimental Biology meeting in San Francisco, April 1-5, and at the 13th Conference on Alternatives to Animal Testing in Linz, Austria, on June 2-4. "These are a great opportunities for our company to demonstrate the advantages of our culture system to a broad audience" said Dr. Dieter Runge, co-founder and CEO of this young biotech company.
PRIMACYT Cell Culture Technology GmbH has its roots in HeparCell GmbH, originally founded by 4 private individuals in June 2004. In December 2004 HeparCell completed a private financing round led by Genius Venture Capital GmbH. In January 2005 HeparCell started its business at the Technologie- und Gewerbezentrum Schwerin. In October 2005 HeparCell GmbH changed its corporate name to PRIMACYT Cell Culture Technology. PRIMACYT is member of BioCon Valley.
BioCon Valley is the initiative for Life Science and health economy of Mecklenburg-Vorpommern, Germany. As one of the German BioRegions BioCon Valley supports the commercial use of modern life sciences and bio- and medical technologies in the region. BioCon Valley s tasks are networking, managing life science centers (bioincubators), project management and coordination, and life science specific public relation. BioCon Valley collaborates in strategic partnership to the life science initiatives at the Baltic Sea (www.scanbalt.org).Contact:
Small but versatile; key players in the marine nitrogen cycle can utilize cyanate and urea
10.12.2018 | Max-Planck-Institut für Marine Mikrobiologie
Carnegie Mellon researchers probe hydrogen bonds using new technique
10.12.2018 | Carnegie Mellon University
What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.
Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...
Scientists at the University of Stuttgart and the Karlsruhe Institute of Technology (KIT) succeed in important further development on the way to quantum Computers.
Quantum computers one day should be able to solve certain computing problems much faster than a classical computer. One of the most promising approaches is...
New Project SNAPSTER: Novel luminescent materials by encapsulating phosphorescent metal clusters with organic liquid crystals
Nowadays energy conversion in lighting and optoelectronic devices requires the use of rare earth oxides.
Scientists have discovered the first synthetic material that becomes thicker - at the molecular level - as it is stretched.
Researchers led by Dr Devesh Mistry from the University of Leeds discovered a new non-porous material that has unique and inherent "auxetic" stretching...
Scientists from the Theory Department of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science (CFEL) in Hamburg have shown through theoretical calculations and computer simulations that the force between electrons and lattice distortions in an atomically thin two-dimensional superconductor can be controlled with virtual photons. This could aid the development of new superconductors for energy-saving devices and many other technical applications.
The vacuum is not empty. It may sound like magic to laypeople but it has occupied physicists since the birth of quantum mechanics.
10.12.2018 | Event News
06.12.2018 | Event News
03.12.2018 | Event News
10.12.2018 | Life Sciences
10.12.2018 | Physics and Astronomy
10.12.2018 | Life Sciences